Teicoplanin and Colistin Induced Nephrotoxicity in A Patient of Septicaemia A Case Report With Emphasis on Morbidity
Teicoplanin and Colistin Induced Nephrotoxicity in A Patient of Septicaemia
DOI:
https://doi.org/10.70284/njirm.v8i4.1294Keywords:
Adverse Drug Reaction, Colistin, Nephrotoxicity, TeicoplaninAbstract
Teicoplanin is a glycopeptides antibiotic active against a broad spectrum of gram positive bacteria with negligible action on Gram negative bacilli. Colistin is polymixin which is active against Gram negative organisms only. Nephrotoxicity has been reported with both Teicoplanin and Colistin. A 52 year old patient diagnosed with septic shock following fecal peritonitis was prescribed Teicoplanin, Meropenem and Colistin. Meropenem was omitted after results of culture sensitivity and other two drugs were continued. This patient had a rise in creatinine levels after 10 days of therapy. Teicoplanin was discontinued on 13th of therapy with improvement in patients condition. Hence physicians need to be aware of this interaction of added nephrotoxicity when combining these two antimicrobials. [Shikha S NJIRM 2017; 8(4):106-108]
References
2. Petrosillo N, Loannidou E, Falagas ME. Colistin monotherapy Vs combination therapy: Evidence from microbiological, animal and clinical studies. Clinical Microbiology and Infection. September 2008;14(9):816-827
3. Rhodes A et al. The Surviving Sepsis Campaign bundles and outcome: results from the international Multicentric Prevalence study on Sepsis. Intensive Care Medicine 2015;41(9):1620-1628
4. Blot S et al. Critical issues in the management of complicated intraabdominal infections. Drugs. 2005.65(12):1611-20.
5. Ferrer R, Loeches I, Phillips G et el. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline based performance improvement programme. Critical Care Medicine. 2014;42(8): 1749-1755
6. Meropenem: A review of its use in the treatment of serious bacterial infections. Drugs. 2008; 68(6):803-38.
7. Wood M et al. The comparative efficacy and safety of Teicoplanin and Vancomycin. Journal of Antimicrobial chemotherapy. 1996; (37):209-22.
8. Kumar A, Ellis P, Arabi Y et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest. 2009; 136(5): 1237-1248
9. Pletz M, Bloos F, Burkhardt O et al. Pharmacokinetics of Moxifloxacin in patients with severe sepsis or septic shock. Intensive Care Medicine. 2010; 36(6): 979-983.
10. Taccone F S, Laterre P F, Sapen H et al. Revisiting the loading dose of Amikacin for patients with severe sepsis and septic shock. Critical care. 2010; 14(2) R3.
